0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pediatric Psoriasis Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-11T14027
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Pediatric Psoriasis Market Research Report 2023
BUY CHAPTERS

Global Pediatric Psoriasis Market Research Report 2023

Code: QYRE-Auto-11T14027
Report
March 2023
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Pediatric Psoriasis Market

The global Pediatric Psoriasis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Pediatric Psoriasis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pediatric Psoriasis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Pediatric Psoriasis in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Pediatric Psoriasis include Abbvie Inc, Amgen Inc, Johnson & Johnson, Novartis Ag, Eli Lilly & Company, Astrazeneca, Celgene Corporation, Merck and Boehringer Ingelheim, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Psoriasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Psoriasis.
The Pediatric Psoriasis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pediatric Psoriasis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Psoriasis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Abbvie Inc
  • Amgen Inc
  • Johnson & Johnson
  • Novartis Ag
  • Eli Lilly & Company
  • Astrazeneca
  • Celgene Corporation
  • Merck
  • Boehringer Ingelheim
  • Leo Pharma

Segment by Type

  • Oral
  • Injection
  • Others

Segment by Application

  • Hospital
  • Clinic
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pediatric Psoriasis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Pediatric Psoriasis Market Report

Report MetricDetails
Report NameGlobal Pediatric Psoriasis Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Psoriasis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric Psoriasis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Psoriasis Market Perspective (2018-2029)
2.2 Pediatric Psoriasis Growth Trends by Region
2.2.1 Global Pediatric Psoriasis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pediatric Psoriasis Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Psoriasis Forecasted Market Size by Region (2024-2029)
2.3 Pediatric Psoriasis Market Dynamics
2.3.1 Pediatric Psoriasis Industry Trends
2.3.2 Pediatric Psoriasis Market Drivers
2.3.3 Pediatric Psoriasis Market Challenges
2.3.4 Pediatric Psoriasis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Psoriasis Players by Revenue
3.1.1 Global Top Pediatric Psoriasis Players by Revenue (2018-2023)
3.1.2 Global Pediatric Psoriasis Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Psoriasis Revenue
3.4 Global Pediatric Psoriasis Market Concentration Ratio
3.4.1 Global Pediatric Psoriasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Psoriasis Revenue in 2022
3.5 Pediatric Psoriasis Key Players Head office and Area Served
3.6 Key Players Pediatric Psoriasis Product Solution and Service
3.7 Date of Enter into Pediatric Psoriasis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Psoriasis Breakdown Data by Type
4.1 Global Pediatric Psoriasis Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Psoriasis Forecasted Market Size by Type (2024-2029)
5 Pediatric Psoriasis Breakdown Data by Application
5.1 Global Pediatric Psoriasis Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Psoriasis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pediatric Psoriasis Market Size (2018-2029)
6.2 North America Pediatric Psoriasis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pediatric Psoriasis Market Size by Country (2018-2023)
6.4 North America Pediatric Psoriasis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Psoriasis Market Size (2018-2029)
7.2 Europe Pediatric Psoriasis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pediatric Psoriasis Market Size by Country (2018-2023)
7.4 Europe Pediatric Psoriasis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Psoriasis Market Size (2018-2029)
8.2 Asia-Pacific Pediatric Psoriasis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pediatric Psoriasis Market Size by Region (2018-2023)
8.4 Asia-Pacific Pediatric Psoriasis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Psoriasis Market Size (2018-2029)
9.2 Latin America Pediatric Psoriasis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pediatric Psoriasis Market Size by Country (2018-2023)
9.4 Latin America Pediatric Psoriasis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Psoriasis Market Size (2018-2029)
10.2 Middle East & Africa Pediatric Psoriasis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pediatric Psoriasis Market Size by Country (2018-2023)
10.4 Middle East & Africa Pediatric Psoriasis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie Inc
11.1.1 Abbvie Inc Company Detail
11.1.2 Abbvie Inc Business Overview
11.1.3 Abbvie Inc Pediatric Psoriasis Introduction
11.1.4 Abbvie Inc Revenue in Pediatric Psoriasis Business (2018-2023)
11.1.5 Abbvie Inc Recent Development
11.2 Amgen Inc
11.2.1 Amgen Inc Company Detail
11.2.2 Amgen Inc Business Overview
11.2.3 Amgen Inc Pediatric Psoriasis Introduction
11.2.4 Amgen Inc Revenue in Pediatric Psoriasis Business (2018-2023)
11.2.5 Amgen Inc Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Pediatric Psoriasis Introduction
11.3.4 Johnson & Johnson Revenue in Pediatric Psoriasis Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis Ag
11.4.1 Novartis Ag Company Detail
11.4.2 Novartis Ag Business Overview
11.4.3 Novartis Ag Pediatric Psoriasis Introduction
11.4.4 Novartis Ag Revenue in Pediatric Psoriasis Business (2018-2023)
11.4.5 Novartis Ag Recent Development
11.5 Eli Lilly & Company
11.5.1 Eli Lilly & Company Company Detail
11.5.2 Eli Lilly & Company Business Overview
11.5.3 Eli Lilly & Company Pediatric Psoriasis Introduction
11.5.4 Eli Lilly & Company Revenue in Pediatric Psoriasis Business (2018-2023)
11.5.5 Eli Lilly & Company Recent Development
11.6 Astrazeneca
11.6.1 Astrazeneca Company Detail
11.6.2 Astrazeneca Business Overview
11.6.3 Astrazeneca Pediatric Psoriasis Introduction
11.6.4 Astrazeneca Revenue in Pediatric Psoriasis Business (2018-2023)
11.6.5 Astrazeneca Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Detail
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Pediatric Psoriasis Introduction
11.7.4 Celgene Corporation Revenue in Pediatric Psoriasis Business (2018-2023)
11.7.5 Celgene Corporation Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Pediatric Psoriasis Introduction
11.8.4 Merck Revenue in Pediatric Psoriasis Business (2018-2023)
11.8.5 Merck Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Detail
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Pediatric Psoriasis Introduction
11.9.4 Boehringer Ingelheim Revenue in Pediatric Psoriasis Business (2018-2023)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Leo Pharma
11.10.1 Leo Pharma Company Detail
11.10.2 Leo Pharma Business Overview
11.10.3 Leo Pharma Pediatric Psoriasis Introduction
11.10.4 Leo Pharma Revenue in Pediatric Psoriasis Business (2018-2023)
11.10.5 Leo Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Pediatric Psoriasis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Oral
    Table 3. Key Players of Injection
    Table 4. Key Players of Others
    Table 5. Global Pediatric Psoriasis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Pediatric Psoriasis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Pediatric Psoriasis Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Pediatric Psoriasis Market Share by Region (2018-2023)
    Table 9. Global Pediatric Psoriasis Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Pediatric Psoriasis Market Share by Region (2024-2029)
    Table 11. Pediatric Psoriasis Market Trends
    Table 12. Pediatric Psoriasis Market Drivers
    Table 13. Pediatric Psoriasis Market Challenges
    Table 14. Pediatric Psoriasis Market Restraints
    Table 15. Global Pediatric Psoriasis Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Pediatric Psoriasis Market Share by Players (2018-2023)
    Table 17. Global Top Pediatric Psoriasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Psoriasis as of 2022)
    Table 18. Ranking of Global Top Pediatric Psoriasis Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Pediatric Psoriasis Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Pediatric Psoriasis Product Solution and Service
    Table 22. Date of Enter into Pediatric Psoriasis Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Pediatric Psoriasis Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Pediatric Psoriasis Revenue Market Share by Type (2018-2023)
    Table 26. Global Pediatric Psoriasis Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Pediatric Psoriasis Revenue Market Share by Type (2024-2029)
    Table 28. Global Pediatric Psoriasis Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Pediatric Psoriasis Revenue Market Share by Application (2018-2023)
    Table 30. Global Pediatric Psoriasis Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Pediatric Psoriasis Revenue Market Share by Application (2024-2029)
    Table 32. North America Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Pediatric Psoriasis Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Pediatric Psoriasis Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Pediatric Psoriasis Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Pediatric Psoriasis Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Pediatric Psoriasis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Pediatric Psoriasis Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Pediatric Psoriasis Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Pediatric Psoriasis Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Pediatric Psoriasis Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Pediatric Psoriasis Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Pediatric Psoriasis Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Abbvie Inc Company Detail
    Table 48. Abbvie Inc Business Overview
    Table 49. Abbvie Inc Pediatric Psoriasis Product
    Table 50. Abbvie Inc Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 51. Abbvie Inc Recent Development
    Table 52. Amgen Inc Company Detail
    Table 53. Amgen Inc Business Overview
    Table 54. Amgen Inc Pediatric Psoriasis Product
    Table 55. Amgen Inc Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 56. Amgen Inc Recent Development
    Table 57. Johnson & Johnson Company Detail
    Table 58. Johnson & Johnson Business Overview
    Table 59. Johnson & Johnson Pediatric Psoriasis Product
    Table 60. Johnson & Johnson Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 61. Johnson & Johnson Recent Development
    Table 62. Novartis Ag Company Detail
    Table 63. Novartis Ag Business Overview
    Table 64. Novartis Ag Pediatric Psoriasis Product
    Table 65. Novartis Ag Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 66. Novartis Ag Recent Development
    Table 67. Eli Lilly & Company Company Detail
    Table 68. Eli Lilly & Company Business Overview
    Table 69. Eli Lilly & Company Pediatric Psoriasis Product
    Table 70. Eli Lilly & Company Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 71. Eli Lilly & Company Recent Development
    Table 72. Astrazeneca Company Detail
    Table 73. Astrazeneca Business Overview
    Table 74. Astrazeneca Pediatric Psoriasis Product
    Table 75. Astrazeneca Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 76. Astrazeneca Recent Development
    Table 77. Celgene Corporation Company Detail
    Table 78. Celgene Corporation Business Overview
    Table 79. Celgene Corporation Pediatric Psoriasis Product
    Table 80. Celgene Corporation Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 81. Celgene Corporation Recent Development
    Table 82. Merck Company Detail
    Table 83. Merck Business Overview
    Table 84. Merck Pediatric Psoriasis Product
    Table 85. Merck Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 86. Merck Recent Development
    Table 87. Boehringer Ingelheim Company Detail
    Table 88. Boehringer Ingelheim Business Overview
    Table 89. Boehringer Ingelheim Pediatric Psoriasis Product
    Table 90. Boehringer Ingelheim Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 91. Boehringer Ingelheim Recent Development
    Table 92. Leo Pharma Company Detail
    Table 93. Leo Pharma Business Overview
    Table 94. Leo Pharma Pediatric Psoriasis Product
    Table 95. Leo Pharma Revenue in Pediatric Psoriasis Business (2018-2023) & (US$ Million)
    Table 96. Leo Pharma Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pediatric Psoriasis Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Pediatric Psoriasis Market Share by Type: 2022 VS 2029
    Figure 3. Oral Features
    Figure 4. Injection Features
    Figure 5. Others Features
    Figure 6. Global Pediatric Psoriasis Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Pediatric Psoriasis Market Share by Application: 2022 VS 2029
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Others Case Studies
    Figure 11. Pediatric Psoriasis Report Years Considered
    Figure 12. Global Pediatric Psoriasis Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Pediatric Psoriasis Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Pediatric Psoriasis Market Share by Region: 2022 VS 2029
    Figure 15. Global Pediatric Psoriasis Market Share by Players in 2022
    Figure 16. Global Top Pediatric Psoriasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Psoriasis as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Pediatric Psoriasis Revenue in 2022
    Figure 18. North America Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Pediatric Psoriasis Market Share by Country (2018-2029)
    Figure 20. United States Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Pediatric Psoriasis Market Share by Country (2018-2029)
    Figure 24. Germany Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Pediatric Psoriasis Market Share by Region (2018-2029)
    Figure 32. China Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Pediatric Psoriasis Market Share by Country (2018-2029)
    Figure 40. Mexico Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Pediatric Psoriasis Market Share by Country (2018-2029)
    Figure 44. Turkey Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Pediatric Psoriasis Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Abbvie Inc Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 47. Amgen Inc Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 49. Novartis Ag Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 50. Eli Lilly & Company Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 51. Astrazeneca Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 52. Celgene Corporation Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 53. Merck Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 54. Boehringer Ingelheim Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 55. Leo Pharma Revenue Growth Rate in Pediatric Psoriasis Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global UV Phototherapy Lamp Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8U13672
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Actinic Keratosis Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20A2320
Wed Feb 21 00:00:00 UTC 2024

Add to Cart

Global Melanoma Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9E6033
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Vitiligo Phototherapy Device Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-15I16746
Mon Feb 19 00:00:00 UTC 2024

Add to Cart